Audit Recording of Q4 and FY26 Earning Conference Call
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Drugs Ltd has notified exchanges that the audio recording of its Q4 and FY26 earnings conference call (originally announced on May 12, 2026) has been uploaded to the company's website. The filing under SEBI Regulation 30 confirms that investors and analysts can access the recording via the company's investor relations section. A full transcript of the call will be shared with exchanges and uploaded to the website at a later date. This is a standard procedural disclosure to comply with continuous listing obligations.
This filing is informational only and does not contain new financial data or strategic updates. Investors seeking details on Q4/FY26 performance, margins, or future guidance should wait for the transcript or refer to the earlier earnings release. No immediate impact on the stock expected from this disclosure alone.